TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Development and Manufacture of HI-6 Powder for Solution

Design and execution of research and development
Other nervous system medicinal products
Research and experimental development services
+1 more
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Ministry of Defence, Defence Science and Technology Laboratory: "Development and Manufacture of HI-6 Powder for Solution". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMinistry of Defence, Defence Science and Technology LaboratoryScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Ministry of Defence, Defence Science and Technology Laboratory
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Ministry of Defence, Defence Science and Technology Laboratory. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMinistry of Defence, Defence Science and Technology Laboratory
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published17 Mar 2023, 11:01 GMT
Last source update17 Mar 2023, 11:01 GMT
Recurring procurementNot published
ClassificationDesign and execution of research and development, Other nervous system medicinal products, Research and experimental development services, Various medicinal products
Delivery area
UK
OCIDocds-h6vhtk-03b3c6
What is being bought
The Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence, intends to award a Single Source Non-Qualifying Defence Contract valued at up to £1,200,000 (EX VAT) with Evonik Corporation of 299 Jefferson Rd, Parsippany, New Jersey, 07054-2827, United States (“the Contractor”) for the development, scale-up, clinical trial and manufacture of HI-6 DMS powder for solution product. The Contractor will provide manufacturing studies necessary for all stages of product development. The Authority will provide the Active Pharmaceutical to the supplier for all activities. In accordance with regulation 4 of The Defence and Security Public Contracts (Amendment) (EU Exit) Regulations 2019 (SI No.2019/697) this procurement falls to be regulated under the provisions of the Defence and Security Public Contracts Regulations 2011 (DSPCR 2011) as amended (in particular by SI 2019/697 and SI 2020/1450).  Prior publication of a contract notice in the Official Journal of the European Union is no longer appropriate. It is considered that this Contract can be placed, using the Negotiated Procedure Without Prior Publication of a Contract Notice pursuant in the UK e-notification service (as required by the relevant legislation) and is lawful in accordance with Regulation 16(1)(a)(i) of the DSPCR 2011 on the basis that the Contractor is the sole applicant to contract notice reference: 030221-2022 as amended by Notice reference 030278-2022.
What changed
From the official release history
  1. Status changed to complete
    17 Mar 2023, 11:01 GMT
  2. Official notice release published
    17 Mar 2023, 11:01 GMT
  3. Buyer information updated
    17 Mar 2023, 11:01 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    The Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence, intends to award a Single Source Non-Qualifying Defence Contract valued at up to £1,200,000 (EX VAT) with Evonik Corporation of 299 Jefferson Rd, Parsippany, New Jersey, 07054-2827, United States (“the Contractor”) for the development, scale-up, clinical trial and manufacture of HI-6 DMS powder for solution product. The Contractor will provide manufacturing studies necessary for all stages of product development. The Authority will provide the Active Pharmaceutical to the supplier for all activities. In accordance with regulation 4 of The Defence and Security Public Contracts (Amendment) (EU Exit) Regulations 2019 (SI No.2019/697) this procurement falls to be regulated under the provisions of the Defence and Security Public Contracts Regulations 2011 (DSPCR 2011) as amended (in particular by SI 2019/697 and SI 2020/1450).  Prior publication of a contract notice in the Official Journal of the European Union is no longer appropriate. It is considered that this Contract can be placed, using the Negotiated Procedure Without Prior Publication of a Contract Notice pursuant in the UK e-notification service (as required by the relevant legislation) and is lawful in accordance with Regulation 16(1)(a)(i) of the DSPCR 2011 on the basis that the Contractor is the sole applicant to contract notice reference: 030221-2022 as amended by Notice reference 030278-2022.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    17 Mar 2023, 11:01 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 17 Mar 2023, 00:00 GMT · £1,200,000
Commercial outcome and competition
Awards
Evonik Corporation
Not published · Not published · active
Contracts
Powder For Solution (PFS)
£1,200,000 · signed 17 Mar 2023, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Ministry of Defence, Defence Science and Technology Laboratory

Contracting authority GB-FTS-77694
View buyer profile

  • Ministry of Defence, Defence Science and Technology Laboratory
    buyer

    Porton Down, Salisbury, Wiltshire, UK, SP4 0JQ
    ADPProcurement@dstl.gov.uk

  • Defence Science and Technology Laboratory
    mediationBody

    Porton Down, Salisbury, Wiltshire, SP4 0JQ

  • Defence Science and Technology Laboratory
    reviewBody

    Porton Down, Salisbury, SP4 0JQ

  • Evonik Corporation
    supplier

    299 Jefferson Road, New Jersey, Parsippany, US, 07054-2827
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence, intends to award a Single Source Non-Qualifying Defence Contract valued at up to £1,200,000 (EX VAT) with Evonik Corporation of 299 Jefferson Rd, Parsippany, New Jersey, 07054-2827, United States (“the Contractor”) for the development, scale-up, clinical trial and manufacture of HI-6 DMS powder for solution product. The Contractor will provide manufacturing studies necessary for all stages of product development. The Authority will provide the Active Pharmaceutical to the supplier for all activities. In accordance with regulation 4 of The Defence and Security Public Contracts (Amendment) (EU Exit) Regulations 2019 (SI No.2019/697) this procurement falls to be regulated under the provisions of the Defence and Security Public Contracts Regulations 2011 (DSPCR 2011) as amended (in particular by SI 2019/697 and SI 2020/1450).  Prior publication of a contract notice in the Official Journal of the European Union is no longer appropriate. It is considered that this Contract can be placed, using the Negotiated Procedure Without Prior Publication of a Contract Notice pursuant in the UK e-notification service (as required by the relevant legislation) and is lawful in accordance with Regulation 16(1)(a)(i) of the DSPCR 2011 on the basis that the Contractor is the sole applicant to contract notice reference: 030221-2022 as amended by Notice reference 030278-2022.